Severe Hemophilia B
Also known as: Severe Haemophilia B / Hemophilia B, Severe
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB16791 | Etranacogene dezaparvovec | An adeno-associated virus vector-based gene therapy used for the treatment of hemophilia B (congenital factor IX deficiency). |
| DB16783 | Fidanacogene elaparvovec | Fidanacogene elaparvovec is an adeno-associated viral (AAV) vector-based gene therapy indicated for the treatment of adults (aged 18 years or older) with moderately severe to severe Hemophilia B (congenital Factor... |
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00100 | Coagulation Factor IX (Recombinant) | 3 | Completed | 2 |
| DB13152 | Coagulation Factor IX Human | 3 | Completed | 1 |
| DB11608 | Eftrenonacog alfa | 3 | Completed | 2 |